Lower respiratory tract disease (LRTD) in patients with cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) study.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Dimpy P Shah, Pankil Shah, Andrew Lachlan Schmidt, Ziad Bakouny, Dimitrios Farmakiotis, Maheen Abidi, Samuel M. Rubinstein, Cesar J. Figueroa, Chris Labaki, Christopher Ryan Friese, Joerg Rathmann, Clara Hwang, Rana R. McKay, Cathleen Park, Matthew Puc, Gayathri Nagaraj, Benjamin French, Jeremy Lyle Warner, Sanjay Shete
Institutions: The University of Texas at San Antonio Health Science Center, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Brown University, University of Colorado Denver, UNC Lineberger Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, University of Michigan, Saint Francis Hospital & Medical Center, Henry Ford Health, Moores Cancer Center, University of Cincinnati, Virtua Health, Loma Linda University Medical Center, Vanderbilt University Medical Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W3171910127